Innovus Pharma launches AllerVarx in Canada for allergic rhinitis

|About: Innovus Pharmaceuticals, Inc. (INNV)|By:, SA News Editor

Innovus Pharmaceuticals (OTCQB:INNV) announces the launch of AllerVarx, a clinically proven, Natural Health Product approved by Health Canada to help reduce symptoms of allergic rhinitis such as nasal discharge, sneezing, nasal congestion and itching.

AllerVarx is the ninth Innovus Pharma product launched in Canada to date and is sold in Europe under the brand name Lertal.

Subscribe for full text news in your inbox